Starting Wegovy is a structured process designed to help your body adjust to the medication while maximizing weight loss results and minimizing side effects. The journey begins with a very low dose and gradually increases over several months to the final maintenance dose. This step-up approach is crucial for allowing your gastrointestinal system to adapt, making the treatment more tolerable and sustainable in the long run. It’s not a quick fix but a progressive therapy that works in tandem with diet and exercise changes.
Before the first injection, a thorough medical evaluation is essential. This isn’t a medication you can simply pick up over the counter. A healthcare provider will assess your health profile, including your Body Mass Index (BMI), which typically needs to be 30 or higher, or 27 or higher with at least one weight-related condition like type 2 diabetes or high blood pressure. They will review your medical history to ensure Wegovy is a safe option for you, especially considering warnings about a potential risk of thyroid C-cell tumors. This initial consultation is the foundation for a safe and effective journey.
Week 1-4: The Starting Dose (0.25 mg)
The first month is all about introduction. The 0.25 milligram dose is sub-therapeutic, meaning it’s not expected to produce significant weight loss on its own. Its primary purpose is to initiate your body’s acclimation to semaglutide, the active ingredient in wegovy. You’ll administer the injection once a week, on the same day each week, into areas like your abdomen, thigh, or upper arm. The pen device is designed for single use and is generally straightforward.
During this phase, you might notice subtle changes. Many people report a slight reduction in appetite and fewer food cravings, particularly for high-fat or sugary foods. Some early side effects are common as your body adjusts. These can include mild nausea, constipation, or diarrhea. It’s vital during this time to focus on dietary modifications. Eating smaller, low-fat meals can significantly help manage potential nausea. Staying hydrated is equally important. While the scale might not show dramatic movement, your body is laying the groundwork for what’s to come.
Week 5-8: Building Tolerance (0.5 mg)
In the second month, the dose doubles to 0.5 mg. This is where the medication’s effects often become more noticeable. The GLP-1 receptor agonist is now at a level where it more effectively slows gastric emptying and acts on the brain’s appetite centers. You’ll likely experience a stronger sensation of fullness after eating even small portions. This is the time to really listen to your body’s signals and stop eating when you feel satisfied, not stuffed.
Weight loss typically becomes more apparent in this period. Clinical trial data suggests an average weight loss of around 5% of initial body weight may be achieved by the end of this month. Side effects might persist or temporarily intensify with the dose increase. Continuing with the dietary strategies from the first month is key. If side effects become bothersome, your doctor may recommend staying on the 0.5 mg dose for an additional month before moving up, as the schedule can be adjusted for tolerability.
Month 3-4: Increasing Efficacy (1.0 mg & 1.7 mg)
Months three and four involve significant dose escalations to 1.0 mg and then 1.7 mg. These are considered intermediate steps on the way to the full dose. The physiological effects are more pronounced. Patients often report that their relationship with food continues to evolve, with a reduced “food noise” or constant thoughts about eating. The weight loss effect accelerates.
By the end of the fourth month at the 1.7 mg dose, many individuals in clinical studies had lost a significant portion of their total target weight. Adherence to the injection schedule and lifestyle changes is critical here. This is also a point where some people might hit a temporary plateau, which is a normal part of any weight loss journey. Mixing up your exercise routine or consulting a nutritionist can help overcome this.
| Time Period | Dose | Primary Focus | Expected Average Weight Loss* | Common Experiences |
|---|---|---|---|---|
| Weeks 1-4 | 0.25 mg | Body Acclimation | ~2-3% | Mild appetite suppression, initial side effects (nausea, constipation). |
| Weeks 5-8 | 0.5 mg | Appetite Control | ~5% | Increased feeling of fullness, more consistent weight loss. |
| Month 3 | 1.0 mg | Metabolic Shift | ~8-10% | Stronger appetite suppression, reduced food cravings. |
| Month 4 | 1.7 mg | Accelerated Loss | ~12-15% | Significant weight loss, potential for temporary plateaus. |
*Based on clinical trial data; individual results will vary.
Month 5 and Beyond: The Maintenance Dose (2.4 mg)
Reaching the 2.4 mg dose marks the beginning of the long-term maintenance phase. This is the dose proven in the STEP clinical trials to produce substantial results. At this level, the medication is working at its full capacity to regulate appetite and calorie intake. The goal shifts from active weight loss to sustaining the weight you’ve lost.
Long-term studies, such as the STEP 4 trial, showed that participants who continued on the 2.4 mg dose for 68 weeks maintained and even continued to experience gradual weight loss. The key to success in this phase is consistency. This includes consistent weekly injections, consistent dietary habits focused on nutrient-dense foods, and consistent physical activity. Regular follow-ups with your healthcare provider are non-negotiable to monitor your progress, manage any ongoing side effects, and ensure the treatment remains effective and safe for you. The journey with Wegovy is a marathon, not a sprint, and the maintenance phase is where the long-term health benefits are truly realized.
Navigating Challenges and Side Effects
It’s important to have a realistic perspective. While many people tolerate Wegovy well, side effects are a common part of the journey, especially during dose increases. The most frequent are gastrointestinal: nausea, vomiting, diarrhea, and constipation. These often subside as your body adjusts, but proactive management is essential. Strategies include eating slowly, avoiding large or high-fat meals, and drinking plenty of water. For constipation, increasing fiber intake or using a mild stool softener as recommended by your doctor can help. Severe or persistent side effects should always be reported to your healthcare provider immediately.
Another challenge can be the cost and insurance coverage for the medication, which can be significant. It’s important to investigate your insurance plan’s criteria for covering weight management medications and explore any patient assistance programs that may be available from the manufacturer. Psychological aspects are also crucial. Weight loss can bring up unexpected emotions, and having a support system, whether through friends, family, or a professional counselor, can be incredibly valuable.